Dr George P Ong, MD | |
850 Walnut Bottom Road, Belvedere Medical Corporation, Carlisle, PA 17013-3698 | |
(717) 245-0272 | |
(717) 243-2357 |
Full Name | Dr George P Ong |
---|---|
Gender | Male |
Speciality | Dermatology |
Location | 850 Walnut Bottom Road, Carlisle, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952387557 | NPI | - | NPPES |
0008327500001 | Medicaid | PA | |
50000625 | Other | CAP BLUE CROSS | |
183204 | Other | HIGHMARK BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | MD022482E (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr George P Ong, MD 850 Walnut Bottom Road, Belvedere Medical Corporation, Carlisle, PA 17013-3698 Ph: (717) 245-0272 | Dr George P Ong, MD 850 Walnut Bottom Road, Belvedere Medical Corporation, Carlisle, PA 17013-3698 Ph: (717) 245-0272 |
News Archive
Intellipharmaceutics International Inc., today announced that the Food and Drug Administration (FDA) has accepted for filing its abbreviated new drug application (ANDA) for a generic version of the antidepressant Effexor XR® (venlafaxine hydrochloride).
Intermedix Corporation, a leading provider of revenue cycle management and software solutions to the emergency healthcare industry, today announced the completion of its previously announced acquisition by Thomas H. Lee Partners, L.P. from Parthenon Capital Partners and its minority shareholders including Glenview Capital Management.
Health care sector revenue increased by 5.7 percent in 2008 to $1.75 trillion, up from $1.66 trillion in 2007, according to new data from the U.S. Census Bureau. This sector is classified under the North American Industry Classification System as NAICS 62.
Liposomes are small fat capsules, often added to beauty products. According to the beauty industry liposomes are capable of transporting active ingredients deep into the skin and release the active ingredients so that they can alter the skin-s structure by rejuvenating and smoothing the skin.
The cover for issue 36 of Oncotarget features, "Knockdown of APOBEC3B is associated with a lower tumor growth in an adrenocortical carcinoma xenograft mouse model," by Gara, et al. which reported that the role of APOBEC3B in adrenocortical carcinoma and the mechanisms through which its expression is regulated in cancer are not fully understood.
› Verified 9 days ago
Julian M. Ngo, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 19 Sprint Dr, Suite 1, Carlisle, PA 17015 Phone: 717-701-8251 Fax: 717-701-8289 |